Concepedia

Author

Karen Rittweger

La Roche College

Also Known As

K Rittweger, K. Rittweger, Karen Rittweger

22

Publications

1.8K

Citations

14

H-Index

23

Concepts

All Affiliations

La Roche CollegeRoche (Switzerland)Memorial Sloan Kettering Cancer CenterHospital Universitario Virgen del RocíoThe University of Texas MD Anderson Cancer Center
KR

About

Karen Rittweger is an author at La Roche College specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

245

2

Pharmacology

5

5

104

3

Pathology

3

3

76

4

Health Sciences

2

2

111

5

Immunology

1

1

16

Karen Rittweger

×

15

Publications

1.8K

Citations

14

H-Index

YearCitations

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Daniel G. Haller, Josep Tabernero, Jean A. Maroun,

Journal of Clinical Oncology

2011

774

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Hans‐Joachim Schmoll, Josep Tabernero, Jean A. Maroun,

Journal of Clinical Oncology

2015

296

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

J Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio,

British Journal of Cancer

2011

224

Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma

Robert J. Motzer, Ashok Rakhit, Michelle S. Ginsberg,

Journal of Clinical Oncology

2001

101

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

David R. Spigel, Martin J. Edelman, Tony Mok,

Clinical Lung Cancer

2012

89

A Phase I/Ii Study of Recombinant Human Interleukin–12 in Patients With Chronic Hepatitis C

Stefan Zeuzem, U. Hopf, Vicente Carréño,

Hepatology

1999

56

Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

Robert J. Motzer, Ashok Rakhit, John F. Thompson,

Annals of Oncology

2002

52

5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

Daniel G. Haller, Josep Tabernero, Jean A. Maroun,

European Journal of Cancer Supplements

2009

38

Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon.

Lawrence J. Eron, Michael Alder, Joanne O’Rourke,

Sexually Transmitted Infections

1993

36

Phase I Evaluation of a 40-kDa Branched-Chain Long-Acting Pegylated IFN-α-2a With and Without Cytarabine in Patients with Chronic Myelogenous Leukemia

Moshe Talpaz, Ashok Rakhit, Karen Rittweger,

Clinical Cancer Research

2005

32

Page 1